Literature DB >> 9520066

Functional evaluation techniques in mitochondrial disorders.

Z Argov1.   

Abstract

Most of the mitochondrial disorders affect the brain and muscle metabolism with variable degrees of impairment. The diagnostic usefulness of the following physiological and imaging methods, which also offer functional information that can be used for follow-up, is critically assessed: lactate levels, exercise testing, phosphorus magnetic resonance spectroscopy (MRS), proton MRS, functional magnetic resonance imaging, positron emission tomography, optical tissue oximetry and single photon emission tomography. Knowledge of the advantages, shortcomings and results of each method in the evaluation of mitochondrial diseases is mandatory before they can be applied to other disorders with suspected oxidative impairment.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9520066     DOI: 10.1159/000007912

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  4 in total

Review 1.  Metabolic myopathies: functional evaluation by different exercise testing approaches.

Authors:  L Volpi; G Ricci; D Orsucci; R Alessi; F Bertolucci; S Piazza; C Simoncini; M Mancuso; G Siciliano
Journal:  Musculoskelet Surg       Date:  2011-03-04

2.  Proton MR spectroscopy in the diagnostic evaluation of suspected mitochondrial disease.

Authors:  Doris D M Lin; Thomas O Crawford; Peter B Barker
Journal:  AJNR Am J Neuroradiol       Date:  2003-01       Impact factor: 3.825

3.  A plasma signature of human mitochondrial disease revealed through metabolic profiling of spent media from cultured muscle cells.

Authors:  Oded Shaham; Nancy G Slate; Olga Goldberger; Qiuwei Xu; Arvind Ramanathan; Amanda L Souza; Clary B Clish; Katherine B Sims; Vamsi K Mootha
Journal:  Proc Natl Acad Sci U S A       Date:  2010-01-08       Impact factor: 11.205

4.  Is metabolic flexibility altered in multiple sclerosis patients?

Authors:  Anja Mähler; Jochen Steiniger; Markus Bock; Alexander U Brandt; Verena Haas; Michael Boschmann; Friedemann Paul
Journal:  PLoS One       Date:  2012-08-28       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.